SCHEMBL23629663

SCHEMBL23629663

CCOC(=O)[C@H](CCC(N)=O)NO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.49
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.46
CAD P27708 1/20 0.45
ALOX15 P16050 2/20 0.40
ALDH1A1 P00352 3/20 0.38
NOD1 Q9Y239 2/20 0.37
MGAM O43451 1/20 0.35
GAA P10253 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
SOAT1 P35610 1/20 0.35
BMP1 P13497 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461495 0.85 L3MBTL1 (0.49) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL28115872 0.85 FOLH1 (0.45) L3MBTL1KMT2AALOX15BMP1BLM
SCHEMBL7608495 0.84 L3MBTL1 (0.56) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL3565347 0.83 L3MBTL1 (0.69) L3MBTL1KMT2APOLBCADALDH1A1
SCHEMBL468757 0.82 L3MBTL1 (0.54) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL468758 0.82 L3MBTL1 (0.54) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL25274352 0.81 CAD (0.47) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL4180273 0.81 L3MBTL1 (0.61) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL4180270 0.81 L3MBTL1 (0.61) L3MBTL1KMT2APOLBCADALOX15
SCHEMBL27392524 0.79 KMT2A (0.36) KMT2AALOX15BMP1BLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122759-A2 OXAZOLIDINONE LIPOSOME COMPOSITIONS AKAGERA MEDICINES, INC. (US) 2023-06-29 WO disclosed
WO-2023112038-A1 NEUTROPHIL EXOCYTOSIS INHIBITORS IMMUNYX PHARMA LTD. (IL) 2023-06-22 WO disclosed
EP-3847650-A1 NUCLEIC ACID ASSEMBLIES FOR USE IN TARGETED DELIVERY The Broad Institute, Inc. (US) 2021-07-14 EP disclosed